Related references
Note: Only part of the references are listed.Osteoprotegerin and Osteopontin Serum Levels are Associated with Vascular Function and Inflammation in Coronary Artery Disease Patients
Konstantinos Maniatis et al.
CURRENT VASCULAR PHARMACOLOGY (2020)
High serum osteopontin levels are associated with prevalent fractures and worse lipid profile in post-menopausal women with type 2 diabetes
T. Filardi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review
Nicole Lioufas et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2019)
Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases
Jeng-Feng Lin et al.
BIOMARKERS IN MEDICINE (2019)
Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus
I Barchetta et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Osteocalcin and carotidufemoral pulse wave velocity in patients on peritoneal dialysis
Po-Jui Chi et al.
TZU CHI MEDICAL JOURNAL (2019)
Association of Pulse Wave Velocity With Chronic Kidney Disease Progression and Mortality Findings From the CRIC Study (Chronic Renal Insufficiency Cohort)
Raymond R. Townsend et al.
HYPERTENSION (2018)
Association between bone metabolism regulators and arterial stiffness in type 2 diabetes patients
S. Sharif et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
The Impact of Osteocalcin, Osteoprotegerin and Osteopontin on Arterial Stiffness in Chronic Renal Failure Patients on Hemodialysis
Botond Csiky et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2017)
THE POTENTIAL CARDIOVASCULAR BENEFITS OF LOW-GLUCOSE DEGRADATION PRODUCT, BIOCOMPATIBLE PERITONEAL DIALYSIS FLUIDS: A REVIEW OF THE LITERATURE
Charlotte E. Grantham et al.
PERITONEAL DIALYSIS INTERNATIONAL (2017)
Aortic Aging in ESRD: Structural, Hemodynamic, and Mortality Implications
Gerard M. London et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients A Cross-Sectional Study
Bang-Gee Hsu et al.
MEDICINE (2016)
Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial
Ahmed D. Abdalrhim et al.
PLOS ONE (2016)
High Serum Sclerostin Levels Are Associated with a Better Outcome in Haemodialysis Patients
Guillaume Jean et al.
NEPHRON (2016)
Osteopontin - A multi-modal marker and mediator in atherosclerotic vascular disease
Talya Wolak
ATHEROSCLEROSIS (2014)
Serum Osteopontin Level Correlates with Carotid-Femoral Pulse Wave Velocity in Geriatric Persons
Chung-Jen Lee et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease
Dimitris Tousoulis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Sclerostin: Another Vascular Calcification Inhibitor?
Kathleen J. Claes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease
Sabrina H. Rossi et al.
BMC NEPHROLOGY (2013)
Large Artery Stiffening and Remodeling Are Independently Associated With All-Cause Mortality and Cardiovascular Events in Chronic Kidney Disease
Alexandre Karras et al.
HYPERTENSION (2012)
Osteopontin predicts survival in critically ill patients with acute kidney injury
Johan M. Lorenzen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease
Johan Lorenzen et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness A Systematic Review and Meta-Analysis
Charalambos Vlachopoulos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Osteopontin: A multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification
Hyun-Ju Cho et al.
CURRENT ATHEROSCLEROSIS REPORTS (2009)
Vascular Calcification: The Killer of Patients with Chronic Kidney Disease
Masahide Mizobuchi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Serum levels of osteopontin are increased in SIRS and sepsis
Rosanna Vaschetto et al.
INTENSIVE CARE MEDICINE (2008)
Visceral Fat, Arterial Stiffness, and Endothelial Function in Peritoneal Dialysis Patients
Qian Lu et al.
JOURNAL OF RENAL NUTRITION (2008)
2007 guidelines for the management of arterial hypertension
Giuseppe Mancia et al.
JOURNAL OF HYPERTENSION (2007)
Structural and genetic bases of arterial stiffness
S Laurent et al.
HYPERTENSION (2005)
Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: Evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo
MY Speer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Smooth muscle cell phenotypic transition associated with calcification - Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers
SA Steitz et al.
CIRCULATION RESEARCH (2001)
Expression, roles, receptors, and regulation of osteopontin in the kidney
YS Xie et al.
KIDNEY INTERNATIONAL (2001)
Share Paper
